Atria Wealth Solutions, Inc. Anavex Life Sciences Corp. Transaction History

Atria Wealth Solutions, Inc.

  • $8.63 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$8.9 - $12.86 $19,909 - $28,767
2,237 Added 14.41%
17,764 $183,000
Q2 2022

Aug 15, 2022
BUY
$7.31 - $12.84 $32,895 - $57,780
4,500 Added 40.81%
15,527 $155,000
Q1 2022

May 16, 2022
BUY
$9.74 - $17.69 $107,402 - $195,067
11,027 New
11,027 $136,000

Others Institutions Holding AVXL

# of Institutions
159
Shares Held
31.6M
Call Options Held
910K
Put Options Held
1.35M
View Full List

About ANAVEX LIFE SCIENCES CORP.

AVXL Quotes by TradingView
  • Ticker AVXL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,942,800
  • Market Cap $352M
  • Description
  • Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...
More about AVXL
Track This Portfolio

Track Atria Wealth Solutions, Inc. Portfolio

Follow Atria Wealth Solutions, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atria Wealth Solutions, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Atria Wealth Solutions, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email